Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis.

Rheumatology and Therapy
Katelynn M Wilton, Eric L Matteson

Abstract

Traditional and biologic disease-modifying antirheumatic drugs (DMARDs) are effective medications for the management of rheumatoid arthritis (RA). However, the effects of these medications on immune function raises concern that they may increase long-term cancer risk. The baseline risk for some cancers appears to differ in patients with RA compared to the general population, with the former having an increased risk of lymphoma, lung cancer and renal cancer, but a decreased risk of colorectal and breast cancer. Some DMARDs appear to increase the rate of specific cancer types (such as bladder cancer with cyclophosphamide), but few appear to increase the overall cancer risk. Studying the link between lymphoma and disease severity in RA is complicated because patients with persistently active disease are at increased risk for lymphoma, and disease severity correlates with more intense use of immunosuppressive medications. Overall, cancer risk in patients with RA is slightly above that of the general population, with the increased risk likely secondary to an increased risk of lymphomas in those with high disease activity. Risk mitigation includes management of RA disease activity as well as age- and sex-appropriate cancer screening.

References

Jan 1, 1994·Annals of Internal Medicine·G GridleyJ F Fraumeni
Feb 17, 1993·Journal of the National Cancer Institute·G GridleyJ F Fraumeni
May 16, 2002·Blood·Xavier MarietteUNKNOWN Investigators of the Club Rhumatismes et Inflammation
Apr 23, 2004·Current Opinion in Rheumatology·Eva BaecklundLars Klareskog
Mar 8, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ted R MikulsThomas M Habermann
Nov 30, 2006·Arthritis and Rheumatism·Eva BaecklundRichard Rosenquist
Nov 6, 2007·Seminars in Arthritis and Rheumatism·Lydia AbásoloUNKNOWN EMECAR Study Group
Feb 27, 2008·Archives of Internal Medicine·Sasha BernatskySamy Suissa
Jun 3, 2008·Arthritis and Rheumatism·Rachelle BuchbinderDamien Jolley
Feb 3, 2009·Cancer Causes & Control : CCC·Arti Parikh-PatelRosemary Cress
Sep 17, 2010·Gut·Farhat V N DinMalcolm G Dunlop
Nov 26, 2010·Seminars in Arthritis and Rheumatism·Loreto CarmonaUNKNOWN EMECAR Study Group
Sep 3, 2011·Arthritis Research & Therapy·Michael H SchiffRonald F van Vollenhoven
Nov 3, 2011·JAMA : the Journal of the American Medical Association·Eric A EngelsMonica Lin
Jul 31, 2012·Annals of the Rheumatic Diseases·Louise Kate MercerUNKNOWN BSRBR Control Centre Consortium
Dec 15, 2012·Rheumatology·Louise K MercerUNKNOWN British Society for Rheumatology Biologics Register (BSRBR) Control Centre Consortium
Jul 3, 2013·The Journal of Surgical Research·Amal AlhefdhiHerbert Chen
Sep 10, 2013·Seminars in Arthritis and Rheumatism·Daniel H SolomonJeffrey D Greenberg

❮ Previous
Next ❯

Citations

Jun 5, 2018·Hematological Oncology·Alina KleinAnat Gafter-Gvili
Jul 31, 2018·Expert Review of Clinical Immunology·Fabiola AtzeniPiercarlo Sarzi-Puttini
Jan 23, 2019·Yonsei Medical Journal·Hwajeong Lee
Jul 13, 2019·International Journal of Rheumatic Diseases·Xin Rong LimUNKNOWN TTSH Rheumatoid Arthritis Study Group
Dec 15, 2019·Clinical Rheumatology·George E Fragoulis, Katerina Chatzidionysiou
Mar 18, 2020·Arthritis & Rheumatology·Rebecca RothwellGregory Levin
Nov 17, 2017·International Journal of Cancer. Journal International Du Cancer·Catherine SchairerShahinaz M Gadalla
Jul 3, 2019·Case Reports in Rheumatology·Georgio MedawarRabih Said
Oct 22, 2020·Dermatologic Therapy·Timothy Tyler Daugherty, Robert Andrew Swerlick
Apr 1, 2019·Best Practice & Research. Clinical Haematology·Prajwal C Boddu, Amer M Zeidan
May 2, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·S JayashreeDipita Bhakta-Guha
Aug 25, 2021·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Monica E D'ArcyEric A Engels

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.